Recent studies demonstrated the role of antioxidants in preventing organ damage caused by free radicals. The present study was conducted to find out the modulatory effect of some antioxidants on lipid patterns in experimentally-induced liver damage. Rats chronically intoxicated with carbon tetrachloride (CC14) were used as a model of liver injury terminating with fibrosis or cirrhosis. One hundred and sixty six albino rats were classified into five groups: one served as a control group; the second was subjected to oral administration of CC14 (200 μL/100 g body weight) twice a week; the other three groups, in addition to CC14, received oral doses of silymarin (30mg/kg), vitamin E (200 IU/kg) and vitamin C (50mg/kg) respectively. At the end of the experiment, the animals were killed, blood was collected and liver was taken for histopathological examination. Liver function tests, disturbed by CC14 were significantly modulated by antioxidants, and histopathological examination showed that antioxidants ameliorated the necrotic and fibrotic changes caused by CC14. Treatment with antioxidants was also shown to modulate the toxic effect of CC14 on the lipid profile and malondialdehyde content. Administration of antioxidants could play an important role in prophylaxis against lipid peroxidation and consequently liver fibrosis caused by free radicals.
PeshlowLHesseS. The milk thistle (Silybum marianum) and silymarin as hepatic therapeutic agents. Z Phytotherap1991; 12: 162–74.
5.
ParolaMLeonarduzziGBiasiFAlbanoEBioccaMEPoliG. Vitamin E dietary supplementation protects against CCl4-induced chronic liver damage and cirrhosis. Hepatology1992; 16: 1014–21.
6.
MaellaroEDeal-BeeloBDSygheriniLPompellaACasiniAComportiM. Protection by ascorbic acid against oxidative injury of isolated hepatocytes. Xenobiotica1994; 24: 281–9.
7.
MachlinLJ. Vitamin E. In: MachlinJM, ed. Handbook of Vitamins.New York: Dekker, 1991: 99.
8.
NikiE. Interaction of ascorbate and α-tocopherol. Ann NY Acad Sci1987; 498: 186–99.
9.
PadhH. Vitamin C: Newer insights into its biochemical functions. Nutr Rev1991; 49: 65–70.
10.
McIntyreN. Plasma lipids and lipoproteins in liver diseases. Gut1978; 19: 526–30.
11.
OwenJS. Extrahepatic cell membrane lipid abnormalities and cellular dysfunction in liver disease. Drugs1990; 40(suppl 3): 73–83.
YamamatoH-A. Relation of Ca++ accumulation and lipid peroxidation with CCl4-induced toxicity in the rat liver. Pharmac Toxicol1990; 66: 213–6.
14.
PoliGCottalassoDPronzatoMChiarpottoEBiasiFCorongiuF. Lipid peroxidation and covalent binding in the early functional impairment of liver Golgi Apparatus by CC14. Cell Biochem Funct1990; 8: 1–10.
15.
FreiAZimmermannAWeignadK. The N-terminal pro-peptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology1984; 5: 330–6.
16.
HalimA-B. Optimization of a protocol for lipid extraction from liver tissue to measure total phospholipid content. Egypt J Biochem1995; 13: 301–10.
17.
UchiyamaMMiharaM. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem1978; 86: 271–87.
18.
MourelleMMurielPFavoriLFrancoT. Prevention of CCl4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol1989; 3: 183–91.
JahnCESchaegferEJTaamLAHoofnagleJHLindgrenFTAlbersJJ. Lipoprotein abnormalities in primary biliary cirihosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology1985; 189: 1266–78.
21.
AragnoMTamagnoEDanniOUgazioG. In vivo studies on halogen compound interactions. III. Effect of carbon tetrachloride plus 1,2 dichloroethane on liver necrosis and fatty accumulation. Res Commun Chem Path Pharmacol1992; 76: 341–54.
22.
DianzaniMU. Reactions of the liver to injury: Fatty liver. In: FarberEFisherMM, eds. Injury of the Liver.New York: Marcel Dekker Inc, 1979: 281–331.
23.
GinterEKubecFJVozarJBobekP. Natural hypocholesterolemic agent. Pectin plus ascorbic acid. Int J Vitam Nutr Res1979; 49: 406–12.
24.
BarakatHADohmGLShuklaNMarksRHKernMCarpenterJW. Influence of age and exercise training on lipid metabolism in fisher-344 rats. J Appl Phyisol1989; 67: 1638–42.
25.
CawthorneMABunyanJSennitMVGreenJGrassoP. Vitamin E and hepatotoxic agents, 3. Vitamin E, synthetic antioxidants and carbon tetrachloride toxicity in the rat. Br J Nutr1970; 24: 357–84.
26.
Di LuzioNR. Antioxidants, lipid peroxidation and chemical-induced liver injury. Fed Proc1973; 32: 1875–81.
27.
IsselbacherKJPodolskyDK. Infiltrative and metabolic diseases affecting the liver. In: IsselbacherKJMartinJBBraunwaldEFauciASWilsonJDKasperDI, eds. Harrison's Principles of Internal Medicine.13th edn.New York: McGraw-Hill Inc, 1994: 1498.
28.
WilliamsRJMotteramJMSharpCHGallagherPJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis1992; 94: 153–9.
29.
KasekiHKimEYWhislerRLCornwellDG. Effect of an oral dose of vitamin E on the vitamin E and cholesterol content of tissues of the vitamin E deficient rat. J Nutr1986; 116: 1631–9.
30.
GinterEBabalaJCervenJ. The effect of chronic hypovitaminosis C on the metabolism of cholesterol and atherogenesis in guinea pigs. J Atherscler Res1969; 10: 341–52.
31.
FidanzaAAudisioM. Vitamins and lipid metabolism. Acta Vitaminol Enzymol1982; 4: 105–14.
HallbergLHogdahlMSvanborgAVikrotO. Plasma lipids in women. Variation in cholesterol, phospholipids and triglycerides at different ages in a random population sample. Acta Medica Scand1966; 180: 697–707.
34.
SatinderAKSarkarSMajumdarSChakravartiRN. Effect of ascorbic acid deficiency on the development of experimental atheroslerosis. Ind J Med Res1987; 86: 351–60.
35.
KanelGCRadvanGPetersRL. High-density lipoprotein-cholesterol and liver disease. Hepatology1983; 3: 343–8.
36.
HermannWJWardKFaucettJ. The effect of tocopherol on high-density lipoprotein-cholesterol. Am J Clin Pathol1979; 72: 848–55.
37.
UchidaKNomuraYTakaseHTasakiTSeoSHayashiY. Effect of vitamin C depletion on serum cholesterol and lipoprotein levels in ODS (od/od) rats unable to synthesize ascorbic acid. J Nutr1990; 120: 1140–7.
38.
FeherJCsomosGVereckeiA. Role of free reactions in liver disease. In: CsomosGFeherJ, eds. Free Radicals and the Liver.Berlin: Springer-Verlag, 1992: 2.
39.
MiraLSilvaMMansoCF. Scavenging of reactive oxygen species by silibinin dithemisuccinate. Biochem Pharmacol1994; 48: 753–9.
40.
CadenasSRojasCPerez-CampoRLopez-TorresMBarjaG. Vitamin E protects guinea pigs liver from lipid peroxidation without depressing levels of antioxidants. Int J Biochem Cell Biol1995; 27: 1175–81.
41.
ChakrabortySNandiAMukhopadhyayM. Ascorbate protects guinea pigs' tissue against lipid peroxidation. Free Rad Biol Med1994; 16: 417–26.
42.
BeckerEMessnerBBerndtJ. Two mechanisms of CCl4-induced fatty liver: lipid peroxidation or covalent binding studies in cultured rat hepatocytes. Freee Rad Res Commun1987; 3: 299–308.
